Bedel Financial Consulting, Inc. Mckesson Corp Transaction History

Bedel Financial Consulting, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$300.57 - $336.42 $57,408 - $64,256	-191 Closed	0 $0
Q1 2022 Apr 19, 2022	SELL	$244.61 - $310.48 $1,956 - $2,483	-8 Reduced 4.02%	191 $58,000
Q4 2021 Jan 11, 2022	BUY	$198.21 - $248.9 $1,585 - $1,991	8 Added 4.19%	199 $49,000
Q3 2020 Oct 20, 2020	SELL	$140.89 - $159.9 $2,395 - $2,718	-17 Reduced 8.17%	191 $28,000
Q2 2020 Jul 14, 2020	SELL	$125.49 - $164.68 $3,513 - $4,611	-28 Reduced 11.86%	208 $32,000

Q4 2018 Jan 28, 2019	BUY	$108.23 - $136.84 $15,909 - $20,115	147 Added 165.17%	236 $26,000
Q3 2018 Nov 01, 2018	SELL	$123.14 - $138.52 $5,048 - $5,679	-41 Reduced 31.54%	89 $11,000
Q2 2018 Jul 18, 2018	SELL	$133.4 - $158.13 $1,334 - $1,581	-10 Reduced 7.14%	130 $17,000
Q1 2018 May 03, 2018	BUY	$138.75 - $176.72 $19,425 - $24,740	140 New	140 $20,000

1,676

109M

676K

678K

Ticker MCK
Exchange NYSE
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 143,730,000
Market Cap $84.5B
Description
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...

Get notified when there are updates to the investment portfolio of Bedel Financial Consulting, Inc., based on Form 13F filings with the SEC.

Stay updated on Bedel Financial Consulting, Inc. with notifications on news.